9/109 sources · 7 publishersUpdated Oct 20, 19:26 UTC
Qiagen in advanced takeover talks as EQT submits binding offer over $50 per share
Private‑equity firm EQT AB has submitted a binding offer to acquire Qiagen NV at a price exceeding $50 per share, valuing the company at more than $10 billion. U.S. buyout firm KKR has also lodged a bid. Qiagen’s board is scheduled to meet this week to review the proposals, while the stock has risen roughly 6% on the news.
Why it matters
The offer represents a premium to Qiagen’s recent closing price, which could lift the share price further if a deal is confirmed (the company’s own filing notes the premium). The transaction would also add a sizable life‑sciences asset to EQT’s portfolio, potentially affecting sector dynamics.
Key facts
- 1EQT AB submitted a binding acquisition offer of over $50 per share for Qiagen. investing.com
- 2U.S. private‑equity firm KKR also submitted a bid for Qiagen. globalbankingandfinance.com
- 3Qiagen’s board is meeting this week to consider the proposals. globalbankingandfinance.com
- 4Qiagen’s market capitalization is €8.57 billion. globalbankingandfinance.com
- 5The stock showed a 5‑day price change of +5.94% on the day of the announcement. marketscreener.com
Open questions
- Materials report different share‑price gains (5.8%, 6%, 7%, 5.94%); the exact intraday percentage is unclear.
Summary written by AlphAI AI Desk from 9 of 9 sources. Not investment advice. Figures are as stated by the linked sources.